IMMUNOPHARMA CONSULTING LTD
No Analysis Available
Get instant AI-powered insights about this company's financial health, risks, and trends.
Order Analysis - £10- Legal registered address
- 20 Westlands Way Oxted Surrey RH8 0ND Copied!
Latest financial results as of 30 July 2025- Cash in bank
- £124.23k
- Current creditors
- £36.39k
- Shareholders funds
- £87.84k
View full financial accounts- Cash in bank
- £124.23k
- Current creditors
- £36.39k
- Shareholders funds
- £87.84k
- Company number
- 06617668 Copied!
Accounts
Latest annual accounts were to 31 August 2024
Next annual accounts are due by 31 May 2026
Company financial year end is on 31 August 2025
Confirmation statement
Latest confirmation statement statement dated 29 November 2024
Next statement due by 13 December 2025
Nature of business (SIC)
72110 - Research and experimental development on biotechnology
Latest company documents
| Date | Description |
|---|---|
| 29/05/2529 May 2025 | Total exemption full accounts made up to 2024-08-31 |
| 29/11/2429 November 2024 | Termination of appointment of Anne Elizabeth Crowe as a director on 2024-11-29 |
| 29/11/2429 November 2024 | Cessation of Anne Elizabeth Crowe as a person with significant control on 2024-11-29 |
| 29/11/2429 November 2024 | Confirmation statement made on 2024-11-29 with updates |
| 29/11/2429 November 2024 | Notification of James Scott Crowe as a person with significant control on 2024-11-29 |
More Company Information
Recently Viewed
Follow Company
- Receive an alert email on changes to financial status
- Early indications of liquidity problems
- Warns when company reporting is overdue
- Free service, no spam emails Follow this company